Skip to main content
. 2020 Feb 10;3(1):3–15. doi: 10.4103/JIPO.JIPO_1_20

Figure 1:

Figure 1:

Summary of key primary resistance mechanisms to immune checkpoint blockade and key strategies that are being employed to overcome the resistance in gastrointestinal cancers. EGFR: Epidermal growth factor receptor, MAPK: Mitogen activated protein kinase pathway, TAM: Tumor associated macrophages, TME: Tumor microenvironment.